Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives

E-ISSN： 2212-3954|7|1|25-40

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.7, Iss.1, 2012-04, pp. : 25-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives

By Prochnau Dirk Figulla Hans R Surber Ralf

Expert Review of Medical Devices, Vol. 10, Iss. 2, 2013-03 ,pp. : 247-256

Informa Healthcare

Access to resources Recommend Favorite

Recent updates and future perspectives in the treatment of electrolyte disorders

By Tzamaloukas Antonios H Glew Robert H

Clinical Practice, Vol. 10, Iss. 6, 2013-11 ,pp. : 679-682

Future Medicine

Access to resources Recommend Favorite

Treatment and management of bacterial vaginosis in pregnancy: current and future perspectives

By Nelson Deborah B

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 267-277

Future Medicine

Access to resources Recommend Favorite

Current treatment options in patients with mastocytosis: status in 2015 and future perspectives

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 474-490

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis

By Uthman Olalekan A. Abdulmalik Jibril

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite